http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040095338-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 |
| filingDate | 2003-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20040095338-A |
| titleOfInvention | Dipyridodiazepinones as reverse transcriptase inhibitors |
| abstract | Compounds of formula I, or salts or prodrugs thereof, useful as inhibitors of HIV reverse transcriptase are described:n n n Formula In n n n n n n n In the above formula,n n n R 2 Is H, halogen, (C 1-4 Alkyl, O (C) 1-4 Alkyl, NH (C 1-4 Alkyl) or N (C 1-4 Alkyl) 2 ego; R 4 H or CH 3 ego; R 5 H or CH 3 ego; R 12 Is H, halogen, (C 1-4 Alkyl, CF 3 , Or NO 2 ego; R 13 Is H, (C 1-4 Alkyl, halogen, OH, or NH 2 Inner, only R 12 And R 13 Are not both H; R 14 COOR 14a Where R 14a Is H or (C 1-6 Is alkyl); R 14 Is (C 2-4 Alkenyl COOR 14a Where R 14a Is as defined above); R 14 Is (C 1-4 Alkyl COOR 14a Where R 14a Is as defined above). |
| priorityDate | 2002-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 195.